Assignee
AMICUS THERAPEUTICS INC
US137 patents
Top patents by PatentIndex Score
US10874655B2Dec 29, 2020
Methods of treating fabry patients having renal impairment
AMICUS THERAPEUTICS INC40 citations99
US10874656B2Dec 29, 2020
Methods of treating Fabry patients having renal impairment
AMICUS THERAPEUTICS INC40 citations99
US10874657B2Dec 29, 2020
Methods of treating Fabry patients having renal impairment
AMICUS THERAPEUTICS INC40 citations99
US10857142B2Dec 8, 2020
Methods of treating Fabry patients having renal impairment
AMICUS THERAPEUTICS INC40 citations99
US10857141B2Dec 8, 2020
Methods of treating Fabry patients having renal impairment
AMICUS THERAPEUTICS INC40 citations99
US10849890B2Dec 1, 2020
Methods of treating Fabry patients having renal impairment
AMICUS THERAPEUTICS INC40 citations99
US10849889B2Dec 1, 2020
Methods of treating Fabry patients having renal impairment
AMICUS THERAPEUTICS INC40 citations99
US10806727B2Oct 20, 2020
Methods of treating fabry patients having renal impairment
AMICUS THERAPEUTICS INC38 citations99
US10799491B2Oct 13, 2020
Methods of treating Fabry patients having renal impairment
AMICUS THERAPEUTICS INC40 citations99
US10792279B2Oct 6, 2020
Methods of treating Fabry patients having renal impairment
AMICUS THERAPEUTICS INC40 citations99
US10792278B2Oct 6, 2020
Methods of treating Fabry patients having renal impairment
AMICUS THERAPEUTICS INC40 citations99
US10471053B2Nov 12, 2019
Methods of treating Fabry patients having renal impairment
AMICUS THERAPEUTICS INC49 citations99
US10251873B2Apr 9, 2019
Methods of treating fabry patients having renal impairment
AMICUS THERAPEUTICS INC52 citations99
US11426396B2Aug 30, 2022
Methods of treating Fabry patients having renal impairment
AMICUS THERAPEUTICS INC11 citations98
US11304940B2Apr 19, 2022
Methods of treating Fabry patients having renal impairment
AMICUS THERAPEUTICS INC11 citations98
US10925866B2Feb 23, 2021
Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones
AMICUS THERAPEUTICS INC38 citations98
US10537564B2Jan 21, 2020
Methods of treating fabry disease in patients having the G9331A mutation in the GLA gene
AMICUS THERAPEUTICS INC52 citations98
US10525045B2Jan 7, 2020
Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones
AMICUS THERAPEUTICS INC49 citations98
US10406143B2Sep 10, 2019
Methods for treatment of fabry disease
AMICUS THERAPEUTICS INC49 citations98
US10383864B2Aug 20, 2019
Methods for treatment of Fabry disease
AMICUS THERAPEUTICS INC49 citations98
US10076514B2Sep 18, 2018
Methods of treating fabry disease in patients having the G9331A mutation in the GLA gene
AMICUS THERAPEUTICS INC53 citations98
US9999618B2Jun 19, 2018
Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones
AMICUS THERAPEUTICS INC51 citations98
US9987263B2Jun 5, 2018
Methods for treatment of Fabry disease
AMICUS THERAPEUTICS INC50 citations98
US9480682B2Nov 1, 2016
Methods for treatment of Fabry disease
AMICUS THERAPEUTICS INC49 citations98
USRE48608EJun 29, 2021
Method to predict response to pharmacological chaperone treatment of diseases
AMICUS THERAPEUTICS INC36 citations97
US10813921B2Oct 27, 2020
Method to predict response to pharmacological chaperone treatment of diseases
AMICUS THERAPEUTICS INC39 citations97
US9545397B2Jan 17, 2017
Method to predict response to pharmacological chaperone treatment of diseases
AMICUS THERAPEUTICS INC50 citations97
US7851143B2Dec 14, 2010
Assays for diagnosing and evaluating treatment options for Fabry disease
AMICUS THERAPEUTICS INC61 citations96
US10357548B2Jul 23, 2019
α-galactosidase A and 1-deoxygalactonojirimycin co-formulation
AMICUS THERAPEUTICS INC49 citations95
US11826360B2Nov 28, 2023
Methods of treating Fabry patients having renal impairment
AMICUS THERAPEUTICS INC4 citations94
US11813255B2Nov 14, 2023
Methods of treating Fabry patients having renal impairment
AMICUS THERAPEUTICS INC4 citations94
US11786516B2Oct 17, 2023
Methods of treating Fabry patients having renal impairment
AMICUS THERAPEUTICS INC4 citations94
US11666564B2Jun 6, 2023
Methods of treating Fabry patients having renal impairment
AMICUS THERAPEUTICS INC7 citations94
US11642334B2May 9, 2023
Methods of treating Fabry patients having renal impairment
AMICUS THERAPEUTICS INC7 citations94
US11633387B2Apr 25, 2023
Methods of treating Fabry patients having renal impairment
AMICUS THERAPEUTICS INC7 citations94
US11633388B2Apr 25, 2023
Methods of treating Fabry patients having renal impairment
AMICUS THERAPEUTICS INC7 citations94
US11622962B2Apr 11, 2023
Methods of treating Fabry patients having renal impairment
AMICUS THERAPEUTICS INC5 citations94
US11612594B2Mar 28, 2023
Methods of treating Fabry patients having renal impairment
AMICUS THERAPEUTICS INC5 citations94
US11612593B2Mar 28, 2023
Methods of treating Fabry patients having renal impairment
AMICUS THERAPEUTICS INC5 citations94
US11389437B2Jul 19, 2022
Methods of treating Fabry patients having renal impairment
AMICUS THERAPEUTICS INC7 citations94
US11357763B2Jun 14, 2022
Methods of treating fabry patients having renal impairment
AMICUS THERAPEUTICS INC7 citations94
US11357765B1Jun 14, 2022
Methods of treating Fabry patients having renal impairment
AMICUS THERAPEUTICS INC9 citations94
US11357762B2Jun 14, 2022
Methods of treating Fabry patients having renal impairment
AMICUS THERAPEUTICS INC7 citations94
US11357761B2Jun 14, 2022
Methods of treating Fabry patients having renal impairment
AMICUS THERAPEUTICS INC7 citations94
US11278537B2Mar 22, 2022
Methods of treating Fabry patients having renal impairment
AMICUS THERAPEUTICS INC7 citations94
US11278538B2Mar 22, 2022
Methods of treating Fabry patients having renal impairment
AMICUS THERAPEUTICS INC7 citations94
US11278540B2Mar 22, 2022
Methods of treating Fabry patients having renal impairment
AMICUS THERAPEUTICS INC7 citations94
US11278539B2Mar 22, 2022
Methods of treating Fabry patients having renal impairment
AMICUS THERAPEUTICS INC7 citations94
US11278536B2Mar 22, 2022
Methods of treating Fabry patients having renal impairment
AMICUS THERAPEUTICS INC7 citations94
US9694056B2Jul 4, 2017
α-galactosidase A and 1-deoxygalactonojirimycin co-formulation
AMICUS THERAPEUTICS INC50 citations94
Showing the top 50 of 137 patents by PatentIndex Score.